Patents by Inventor Thomas C. Evans
Thomas C. Evans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10597650Abstract: Compositions and methods are provided for ligating polynucleotides having a length that is greater than 8 nucleotides on an RNA splint. The ligation reaction provides consistent results in high or low ATP concentrations. The reaction can occur rapidly and is generally at least 10 fold more efficient than T4DNA ligase under optimal conditions for T4DNA ligase and the reaction time is less than 6 hours for example, less than 1 hour.Type: GrantFiled: March 14, 2013Date of Patent: March 24, 2020Assignee: New England Biolabs, Inc.Inventors: Gregory Lohman, Thomas C. Evans, Larry A. McReynolds
-
Patent number: 9826101Abstract: Policies that govern allocation of spectrum access credentials are established. The policies are configured to implement regulatory rules governing spectrum use in a geographic area. Policy establishment includes selecting, from a collection of predetermined general policy constructs that are generic to plural regulatory domains, general policy constructs to transform into protection instances. Policy parameter inputs are applied to policy parameter fields of the selected general policy constructs to establish the protection instances, the protection instances specify how regulatory rules are applied in the geographic area. Protection data values are applied to protection data fields of the protection instances to create instances of policies that are specific to the geographic area according to incumbent spectrum use in the geographic area.Type: GrantFiled: September 9, 2016Date of Patent: November 21, 2017Inventors: Jeffrey C. Schmidt, Thomas C. Evans, Peter Stanforth, Robin U. Roberts, Santosh Hari, Sekhar V. Uppalapati
-
Publication number: 20170078492Abstract: Policies that govern allocation of spectrum access credentials are established. The policies are configured to implement regulatory rules governing spectrum use in a geographic area. Policy establishment includes selecting, from a collection of predetermined general policy constructs that are generic to plural regulatory domains, general policy constructs to transform into protection instances. Policy parameter inputs are applied to policy parameter fields of the selected general policy constructs to establish the protection instances, the protection instances specify how regulatory rules are applied in the geographic area. Protection data values are applied to protection data fields of the protection instances to create instances of policies that are specific to the geographic area according to incumbent spectrum use in the geographic area.Type: ApplicationFiled: September 9, 2016Publication date: March 16, 2017Inventors: Jeffrey C. Schmidt, Thomas C. Evans, Peter Stanforth, Robin U. Roberts, Santosh Hari, Sekhar V. Uppalapati
-
Patent number: 9580748Abstract: Methods are provided for a rapid, low cost approach to monitoring an amplification reaction. This includes monitoring the progress of isothermal or PCR amplification reactions to completion using pH-sensitive dyes that are either colored or fluorescent. Compositions are described that include a mixture of a DNA polymerase, deoxyribonucleotide triphosphate and a weak buffer of less than 1 mM Tris or equivalent or no buffer.Type: GrantFiled: April 7, 2015Date of Patent: February 28, 2017Assignee: New England BioLabs, Inc.Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
-
Patent number: 9546358Abstract: Compositions are provided that include a plurality of small molecules selected from the group consisting of an amide, urea or acetone having a molecular weight less than 300 g/mol; and dNTPs and a polymerase in a buffer suitable for use as an amplification buffer. Methods of use of the compositions are also described for reducing non-template DNA amplification.Type: GrantFiled: March 13, 2013Date of Patent: January 17, 2017Assignee: New England Biolabs, Inc.Inventors: Nathan Tanner, Thomas C. Evans
-
Patent number: 9549380Abstract: Spectrum that is shared by two or more radio devices that operate near a boundary of a tract is managed by a spectrum management system. The system determines a closest point of approach to the boundary for each radio device and an aggregate contributed power at each closest point of approach by the emissions from the radio devices previously granted spectrum access to the shared spectrum. A transmit power limit for the requesting radio device is determined at each closest point of approach. Spectrum access is granted to a requesting radio device and the granted spectrum access includes an authorized transmit power limit that does not exceed the smallest one of the transmit power limits.Type: GrantFiled: June 10, 2016Date of Patent: January 17, 2017Assignee: Spectrum Bridge, Inc.Inventors: Jeffrey C. Schmidt, Robin U. Roberts, Thomas C. Evans
-
Publication number: 20160366655Abstract: Spectrum that is shared by two or more radio devices that operate near a boundary of a tract is managed by a spectrum management system. The system determines a closest point of approach to the boundary for each radio device and an aggregate contributed power at each closest point of approach by the emissions from the radio devices previously granted spectrum access to the shared spectrum. A transmit power limit for the requesting radio device is determined at each closest point of approach. Spectrum access is granted to a requesting radio device and the granted spectrum access includes an authorized transmit power limit that does not exceed the smallest one of the transmit power limits.Type: ApplicationFiled: June 10, 2016Publication date: December 15, 2016Inventors: Jeffrey C. Schmidt, Robin U. Roberts, Thomas C. Evans
-
Publication number: 20150240293Abstract: Methods are provided for a rapid, low cost approach to monitoring an amplification reaction. This includes monitoring the progress of isothermal or PCR amplification reactions to completion using pH-sensitive dyes that are either colored or fluorescent. Compositions are described that include a mixture of a DNA polymerase, deoxyribonucleotide triphosphate and a weak buffer of less than 1 mM Tris or equivalent or no buffer.Type: ApplicationFiled: April 7, 2015Publication date: August 27, 2015Applicant: NEW ENGLAND BIOLABS, INC.Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
-
Patent number: 9109226Abstract: Compositions and methods are provided for inhibiting a polymerase from replicating non target DNA at a temperature below the amplification reaction temperature. The inhibitor is a synthetic nucleic acid which is single stranded but folds to form at least one double stranded region designed to melt at a temperature which is lower than the amplification reaction temperature, and at least one single stranded region where the single stranded region at the 5? end contains at least one uracil or inosine and optionally a sequence at the 3? end contains one or more derivative nucleotide or linkages.Type: GrantFiled: March 15, 2013Date of Patent: August 18, 2015Assignee: New England Biolabs, Inc.Inventors: Jennifer Ong, Donald Johnson, Thomas C. Evans, Lucia Greenough
-
Patent number: 9074249Abstract: Compositions and methods are provided for quantitative detection of amplification products, the methods being suitable for multiplexing. A first oligonucleotide that includes a primer sequence for priming an amplification reaction and also is labeled with a fluorescent label or quencher is mixed with a second oligonucleotide which has a sequence suitable for hybridizing to a portion of the first oligonucleotide and has a fluorescent label if the first oligonucleotide has a quencher or a quencher if the first oligonucleotide has a fluorescent label; and a third nucleotide which includes some or all the primer sequence contained in the first oligonucleotide but is not labeled, the first and third oligonucleotide being combined in a molar ratio of 2.8 to 8.2.Type: GrantFiled: March 15, 2013Date of Patent: July 7, 2015Assignee: New England Biolabs, Inc.Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
-
Patent number: 9074243Abstract: Compositions and methods are provided for quantitative detection of amplification products, the methods being suitable for multiplexing. A first oligonucleotide that includes a primer sequence for priming an amplification reaction and also is labeled with a fluorescent label or quencher is mixed with a second oligonucleotide which has a sequence suitable for hybridizing to a portion of the first oligonucleotide and has a fluorescent label if the first oligonucleotide has a quencher or a quencher if the first oligonucleotide has a fluorescent label; and a third nucleotide which includes some or all the primer sequence contained in the first oligonucleotide but is not labeled, the first and third oligonucleotide being combined in a molar ratio of 2.8 to 8.2.Type: GrantFiled: March 14, 2013Date of Patent: July 7, 2015Assignee: New England Biolabs, Inc.Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
-
Patent number: 9034606Abstract: Methods are provided for a rapid, low cost approach to monitoring an amplification reaction. This includes monitoring the progress of isothermal or PCR amplification reactions to completion using pH-sensitive dyes that are either colored or fluorescent. Compositions are described that include a mixture of a DNA polymerase, deoxyribonucleotide triphosphate and a weak buffer of less than 1 mM Tris or equivalent or no buffer.Type: GrantFiled: March 13, 2013Date of Patent: May 19, 2015Assignee: New England Biolabs, Inc.Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
-
Patent number: 8948801Abstract: A provisioning engine provisions spectrum into an allocable spectrum object. The provisioning engine includes an interface configured to receive inputs of available spectrum information and a plurality of provisioning parameters. The plurality of provisioning parameters include at least one signal strength limit, and may include at least first and second signal strength limits that may be boundary strength limit and an allocation strength limit. A controller is configured to execute a spectrum provisioning application that is stored in a memory and, by execution of the spectrum provisioning application, the provisioning engine is configured to generate an allocable spectrum object in accordance with the provisioning parameters. Spectrum encompassed within the spectrum object is allocable by an allocation engine to spectrum users in accordance with the provisioning parameters.Type: GrantFiled: July 16, 2012Date of Patent: February 3, 2015Assignee: Spectrum Bridge, Inc.Inventors: Jeffrey C. Schmidt, Thomas C. Evans, Hrishikesh Gossain, Manish Shukla
-
Patent number: 8883474Abstract: Compositions and methods are provided that relate to solubilized phospholipids and their use in stabilizing nucleic acid polymerases. For example, a phospholipid with a tail containing at least 8 carbons can be solubilized in the presence of an amphipathic molecule.Type: GrantFiled: December 20, 2013Date of Patent: November 11, 2014Assignee: New England Biolabs, IncInventors: Donald Johnson, Thomas C. Evans
-
Patent number: 8824970Abstract: A spectrum use assessment server receives spectrum use data from each of plural electronic devices. The spectrum use data from each electronic device includes at least location of the electronic device and operating channel of the electronic device. The server determines a spectrum use coverage area of each electronic device and identifies an overlap in the coverage areas in which two or more of the electronic devices engage in competing spectrum use.Type: GrantFiled: September 12, 2012Date of Patent: September 2, 2014Assignee: Spectrum Bridge, Inc.Inventors: Jeffrey C. Schmidt, Don Joslyn, Thomas C. Evans
-
Publication number: 20140179539Abstract: Compositions and methods are provided for ligating polynucleotides having a length that is greater than 8 nucleotides on an RNA splint. The ligation reaction provides consistent results in high or low ATP concentrations. The reaction can occur rapidly and is generally at least 10 fold more efficient than T4DNA ligase under optimal conditions for T4DNA ligase and the reaction time is less than 6 hours for example, less than 1 hour.Type: ApplicationFiled: March 14, 2013Publication date: June 26, 2014Applicant: NEW ENGLAND BIOLABS, INC.Inventors: Gregory Lohman, Thomas C. Evans
-
Publication number: 20140073259Abstract: A spectrum use assessment server receives spectrum use data from each of plural electronic devices. The spectrum use data from each electronic device includes at least location of the electronic device and operating channel of the electronic device. The server determines a spectrum use coverage area of each electronic device and identifies an overlap in the coverage areas in which two or more of the electronic devices engage in competing spectrum use.Type: ApplicationFiled: September 12, 2012Publication date: March 13, 2014Inventors: Jeffrey C. Schmidt, Don Joslyn, Thomas C. Evans
-
Publication number: 20140057268Abstract: Methods are provided for a rapid, low cost approach to monitoring an amplification reaction. This includes monitoring the progress of isothermal or PCR amplification reactions to completion using pH-sensitive dyes that are either colored or fluorescent. Compositions are described that include a mixture of a DNA polymerase, deoxyribonucleotide triphosphate and a weak buffer of less than 1 mM Tris or equivalent or no buffer.Type: ApplicationFiled: March 13, 2013Publication date: February 27, 2014Applicant: NEW ENGLAND BIOLABS, INC.Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
-
Publication number: 20140031248Abstract: Compositions and methods are provided for quantitative detection of amplification products, the methods being suitable for multiplexing. A first oligonucleotide that includes a primer sequence for priming an amplification reaction and also is labeled with a fluorescent label or quencher is mixed with a second oligonucleotide which has a sequence suitable for hybridizing to a portion of the first oligonucleotide and has a fluorescent label if the first oligonucleotide has a quencher or a quencher if the first oligonucleotide has a fluorescent label; and a third nucleotide which includes some or all the primer sequence contained in the first oligonucleotide but is not labeled, the first and third oligonucleotide being combined in a molar ratio of 2.8 to 8.2.Type: ApplicationFiled: March 14, 2013Publication date: January 30, 2014Applicant: NEW ENGLAND BIOLABS, INC.Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans
-
Publication number: 20130323738Abstract: Compositions and methods are provided for quantitative detection of amplification products, the methods being suitable for multiplexing. A first oligonucleotide that includes a primer sequence for priming an amplification reaction and also is labeled with a fluorescent label or quencher is mixed with a second oligonucleotide which has a sequence suitable for hybridizing to a portion of the first oligonucleotide and has a fluorescent label if the first oligonucleotide has a quencher or a quencher if the first oligonucleotide has a fluorescent label; and a third nucleotide which includes some or all the primer sequence contained in the first oligonucleotide but is not labeled, the first and third oligonucleotide being combined in a molar ratio of 2.8 to 8.2.Type: ApplicationFiled: March 15, 2013Publication date: December 5, 2013Applicant: NEW ENGLAND BIOLABS, INC.Inventors: Nathan Tanner, Yinhua Zhang, Thomas C. Evans